When it comes to drug development, precision is more than a goal—it’s a necessity. At Olon USA, we pride ourselves on delivering custom stable labeled bioanalytical standards that provide the accuracy you need to move your projects forward with confidence. Our latest blog delves into how our tailor-made solutions are crafted to meet the specific needs of your projects. Learn how we bring together advanced technology, in-depth scientific knowledge, and a commitment to quality to support your journey from discovery to market. Click here to read more: https://lnkd.in/gw_jD9hB #BioanalyticalStandards #DrugDevelopment #Pharma #StableLabeling #InnovativeSolutions
Über uns
Who we are: On June 9, 2017, Olon S.p.A., a leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and Generics supplier, announced the acquisition of Ricerca Biosciences’ Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry and benefits Ricerca Biosciences' customer base by providing large-scale manufacturing capabilities in Europe. Olon Ricerca Bioscience is a US-based CRO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution. Olon Ricerca’s extensive process/synthetic chemistry, analytical chemistry and engineering expertise provides a synergy that excels at first-time scale-ups and subsequent development of safe, reliable, robust and cost-effective manufacturing processes. For more than 25 years, Olon Ricerca has a record of on-time delivery and quality, providing comprehensive support and problem solving for successful development, scale-up and process-optimized manufacture of pharmaceutical ingredients. Company Details Website: http://www.olonricerca.com Location: Concord, OH
- Website
-
http://www.olon-usa.com
External link for Olon USA
- Industrie
- Pharmaceutical Manufacturing
- Größe des Unternehmens
- 51-200 Mitarbeiter
- Hauptsitz
- Concord, OH
- Typ
- In Privatbesitz
- Gegründet
- 2017
- Spezialitäten
- Chemical Development, Synthetic Chemistry, Analytical Services, CRO, CDMO, API, GMP, GLP, Drug Substance, and generic
Standorte
-
Primäre
7528 Auburn Rd
Concord, OH 44077, US
-
100 Campus Drive
Florham Park, NJ 07932, US
Employees at Olon USA
Aktualisierungen
-
Join Olon USA as we make our mark at CPHI Worldwide 2024 in Milan, Italy! Visit us at Stand 1B2, API to explore our state-of-the-art API development and manufacturing services. Discover our comprehensive risk management strategies, client-centric services, and tailored solutions for all phases of drug development. Click here to learn more: https://lnkd.in/gcQyTe7b Don't miss the chance to book a meeting with our experts and explore how we can drive your projects forward with efficiency and innovation. #CPHIWorldwide2024 #DrugDevelopment #APIManufacturing #Olon #OlonUSA
Olon USA Heads to Milan: What to Expect from Us at CPHI Worldwide 2024 - Olon USA
https://olon-usa.com
-
Olon USA reposted this
We are pleased to announce that we have obtained the CEP for the active ingredient #Rotigotine, ready to supply the product as flexible and sustainable source, EU registered and CEP based countries. Rotigotine is a molecule used to treat #Parkinson's Disease. #Olon has developed a proprietary, innovative process that allows us to obtain a product with a particularly high degree of purity and high efficiency standards. “The international collaboration between Italy and the United States was key to achieving the brilliant result. The work teams have successfully finalized the technology transfer of the product to Olon USA so that we are able to provide the API from different sites and satisfy the different regulatory and patent needs of customers" @Giorgio Bertolini, Senior VP R&D, commented
-
-
We're thrilled to announce a game-changing development at Olon USA! Our parent company, Olon, has acquired GTP Bioways, a leading French CDMO specializing in biopharmaceutical development. This strategic move expands our capabilities, allowing us to offer a comprehensive range of services from small molecule to large molecule development and manufacturing. Click here to learn more: https://lnkd.in/ga48K4qD We're excited to support our clients with even more innovative solutions, particularly in the rapidly growing oncology space. #OlonUSA #Olon #BioPharma #Oncology #DrugDevelopment
Olon Expands Capabilities with Acquisition of GTP Bioways - Olon USA
https://olon-usa.com
-
Olon USA reposted this
ONCOLOGY. FROM CYTOTOXIC COMPOUNDS TO HIGHLY SELECTIVE APPROACHES. Read the full story of our long lasting expertise in manufacturing #API in high containment. This is the thought leadership article by Giorgio Bertolini published by Specialty Chemicals Magazines Thank you Andrew Warmington https://joom.ag/Njtd/p24
Speciality Chemicals Magazine JUL / AUG 2024 | Page 24
viewer.joomag.com
-
The team at Olon USA would like to wish a #HappyIndependenceDay to our US friends, colleagues and clients! #Happy4thOfJuly
-
-
From Lab to Market: Olon USA’s Chemical Development Expertise We are excited to share our latest blog, showcasing Olon USA’s comprehensive expertise in chemical development. Learn how we transform innovative ideas from the lab into market-ready solutions, ensuring every step of the development process is efficient, effective, and of the highest quality. Our blog highlights: ✅ Cutting-edge technologies and methodologies ✅ Expert teams dedicated to innovation ✅ Commitment to excellence in every project phase Discover how Olon USA’s chemical development capabilities can accelerate your journey from concept to commercialization. Click here to learn more: https://lnkd.in/gsMnk6Pb #ChemicalDevelopment #PharmaceuticalInnovation #LabToMarket #QualityExcellence #PharmaTech
From Lab to Market: Olon USA's Chemical Development Expertise - Olon USA
https://olon-usa.com
-
Accelerating Drug Development with Olon USA Stay ahead in the fast-paced pharmaceutical industry with insights from Olon USA’s latest blog! We discuss the state of the industry and reveal how our advanced technologies and innovative strategies are speeding up the drug development process. Discover our comprehensive analytical services, dedication to quality, and how we can help you overcome development challenges. Ready to accelerate your drug development process? Read more about our innovative approach: https://lnkd.in/gGwzDcrb #PharmaceuticalIndustry #DrugDevelopment #IndustryLeadership #QualityCommitment
The State of the Pharmaceutical Industry: Olon USA's Approach to Accelerating Drug Development - Olon USA
https://olon-usa.com